Nxera Pharma Co., Ltd. ( SOLTF) - Stock Earnings
SOLTF Quarterly earnings
Analyst consensus estimates are available to paid members.
| Date | Earnings | Revenue |
|---|---|---|
| 2025Q4 | -49.3 million USD | 49.6 million USD |
| 2026Q1 | 11.3 million USD | 70.9 million USD |
| 2026Q2 | -1.2 million USD | 46.7 million USD |
| 2026Q3 Est. | — | — |
| 2026Q4 Est. | — | — |
SOLTF Yearly earnings
Analyst consensus estimates are available to paid members.
| Date | Earnings | Revenue |
|---|---|---|
| 2023 | -51.0 million USD | 90.5 million USD |
| 2024 | -30.8 million USD | 183.9 million USD |
| 2025 | -80.1 million USD | 189.2 million USD |
| 2026 Est. | — | — |
SOLTF
Price: $5.01
52 week price:
Payout Ratio Range:
Earnings Per Share: -0.56 USD
Exchange: PNK
Sector: Healthcare
Industry: Biotechnology
Market Capitalization: 457.8 million